| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2766514 | Medicina Paliativa | 2011 | 8 Pages |
Abstract
Between 46-90% of the 157 patients treated with 200Â mg of modafinil had a significant improvement in fatigue. There were significant improvements in fatigue in two of the three randomised trials. Modafinil had a good tolerance in all of them. These results justify further research into the treatment of cancer-related fatigue, and meanwhile modafinil could be considered as an alternative for cancer - related fatigue.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
MarÃa Angustias Portela, Carlos Centeno, Álvaro Sanz Rubiales,